STOCK TITAN

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company, has scheduled its fourth quarter and full year 2024 financial results announcement for Wednesday, March 26, 2025, before U.S. markets open.

The company will host a conference call at 10:00 a.m. EST to discuss financial results and corporate updates. Investors can participate using the following dial-in numbers:

  • U.S. investors: 1-877-407-9716
  • International investors: 1-201-493-6779
  • Israel investors: 1-809-406-247
A live audio webcast will be available in listen-only mode, with a replay accessible on the company's website for a time. Questions for management can be submitted in advance to Dan Ferry at LifeSci Advisors.

CollPlant Biotechnologies (NASDAQ: CLGN), un'azienda nel campo della medicina rigenerativa e estetica, ha programmato l'annuncio dei risultati finanziari del quarto trimestre e dell'intero anno 2024 per mercoledì 26 marzo 2025, prima dell'apertura dei mercati statunitensi.

L'azienda ospiterà una conferenza telefonica alle 10:00 EST per discutere i risultati finanziari e gli aggiornamenti aziendali. Gli investitori possono partecipare utilizzando i seguenti numeri di telefono:

  • Investitori statunitensi: 1-877-407-9716
  • Investitori internazionali: 1-201-493-6779
  • Investitori israeliani: 1-809-406-247
Un webcast audio dal vivo sarà disponibile in modalità solo ascolto, con una registrazione accessibile sul sito web dell'azienda per un certo periodo di tempo. Le domande per la direzione possono essere inviate in anticipo a Dan Ferry di LifeSci Advisors.

CollPlant Biotechnologies (NASDAQ: CLGN), una empresa de medicina regenerativa y estética, ha programado el anuncio de resultados financieros del cuarto trimestre y del año completo 2024 para miércoles 26 de marzo de 2025, antes de la apertura de los mercados en EE. UU.

La empresa llevará a cabo una conferencia telefónica a las 10:00 a.m. EST para discutir los resultados financieros y las actualizaciones corporativas. Los inversores pueden participar utilizando los siguientes números de acceso:

  • Inversores de EE. UU.: 1-877-407-9716
  • Inversores internacionales: 1-201-493-6779
  • Inversores de Israel: 1-809-406-247
Se dispondrá de una transmisión de audio en vivo en modo solo escucha, con una repetición accesible en el sitio web de la empresa durante un tiempo determinado. Las preguntas para la dirección pueden enviarse por adelantado a Dan Ferry de LifeSci Advisors.

CollPlant Biotechnologies (NASDAQ: CLGN), 재생 및 미용 의학 회사가 2025년 3월 26일 수요일에 2024년 4분기 및 연간 재무 결과 발표를 예정하고 있습니다. 미국 시장 개장 전에 발표됩니다.

회사는 동부 표준시 기준 오전 10시에 재무 결과 및 기업 업데이트에 대해 논의하기 위한 전화 회의를 개최할 것입니다. 투자자들은 다음 전화번호를 사용하여 참여할 수 있습니다:

  • 미국 투자자: 1-877-407-9716
  • 국제 투자자: 1-201-493-6779
  • 이스라엘 투자자: 1-809-406-247
라이브 오디오 웹캐스트는 청취 전용 모드로 제공되며, 회사 웹사이트에서 일정 기간 동안 재생할 수 있습니다. 경영진에게 질문은 LifeSci Advisors의 Dan Ferry에게 사전 제출할 수 있습니다.

CollPlant Biotechnologies (NASDAQ: CLGN), une entreprise de médecine régénérative et esthétique, a prévu l'annonce de ses résultats financiers du quatrième trimestre et de l'année complète 2024 pour mercredi 26 mars 2025, avant l'ouverture des marchés américains.

L'entreprise organisera une conférence téléphonique à 10h00 EST pour discuter des résultats financiers et des mises à jour de l'entreprise. Les investisseurs peuvent participer en utilisant les numéros suivants :

  • Investisseurs américains : 1-877-407-9716
  • Investisseurs internationaux : 1-201-493-6779
  • Investisseurs israéliens : 1-809-406-247
Un webinaire audio en direct sera disponible en mode écoute seule, avec un replay accessible sur le site web de l'entreprise pendant un certain temps. Les questions pour la direction peuvent être soumises à l'avance à Dan Ferry de LifeSci Advisors.

CollPlant Biotechnologies (NASDAQ: CLGN), ein Unternehmen für regenerative und ästhetische Medizin, hat die Bekanntgabe der Finanzzahlen für das vierte Quartal und das gesamte Jahr 2024 für Mittwoch, den 26. März 2025, vor der Eröffnung der US-Märkte angesetzt.

Das Unternehmen wird um 10:00 Uhr EST eine Telefonkonferenz abhalten, um die finanziellen Ergebnisse und Unternehmensupdates zu besprechen. Investoren können über die folgenden Telefonnummern teilnehmen:

  • US-Investoren: 1-877-407-9716
  • Internationale Investoren: 1-201-493-6779
  • Investoren aus Israel: 1-809-406-247
Ein Live-Audio-Webcast wird im Nur-Zuhören-Modus verfügbar sein, mit einer Wiederholung, die für eine bestimmte Zeit auf der Unternehmenswebsite zugänglich ist. Fragen an das Management können im Voraus an Dan Ferry von LifeSci Advisors gesendet werden.

Positive
  • None.
Negative
  • None.

Conference call to be held on Wednesday, March 26, 2025 at 10:00 a.m. U.S. EST

REHOVOT, Israel, March 19, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq:  CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for medical aesthetics and tissue regeneration, today announced that it will report financial results for the fourth quarter and full year of 2024 on Wednesday, March 26, 2025, before the opening of the U.S. financial markets. The Company will then host a conference call, the audio of which will be webcast to discuss its financial results and corporate updates on Wednesday, March 26th at 10:00 a.m. Eastern Standard Time.

 

CollPlant logo

 

Conference call information

To participate in the conference call, please use the dial-in information below:

U.S. investors: 1-877-407-9716 
Investors outside of the U.S.: 1-201-493-6779 
Israel investors: 1-809-406-247
Conference ID: 13750725

Note, you can avoid long wait times for the operator by using the Call me™ feature and clicking the link below 15 minutes prior to the scheduled call start time:

https://callme.viavid.com/viavid/?callme=true&passcode=13728588&h=true&info=company-email&r=true&B=6

 

 

Webcast information 

A live audio only webcast will also be available in listen-only mode and  can be accessed here or via the link to be posted on the News & Events section of the CollPlant Investor relations website. A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the Company's website for a limited time.

Submit questions to management in advance of the call

To ask management a question ahead of the call, please email Dan Ferry at LifeSci Advisors, LLC up until 24 hours before the event at daniel@lifesciadvisors.com.

About CollPlant

CollPlant is a regenerative and aesthetic medicine company ushering in a new era of medical solutions with a focus on medical aesthetics and 3D bioprinting of tissues and organs. The Company's products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant-based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing.

In 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market.

For more information about CollPlant, visit http://www.collplant.com

Contacts

CollPlant:    

Investor:

Eran Rotem  

Daniel Ferry

Deputy CEO & CFO

Managing Director

Tel: +972-73-2325600 

LifeSci Advisors, LLC

Email: eran@collplant.com   

daniel@lifesciadvisors.com

Logo - https://mma.prnewswire.com/media/2217353/CollPlant_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information-302405677.html

SOURCE CollPlant

FAQ

When will CollPlant (CLGN) release its Q4 and full year 2024 earnings?

CollPlant will release its Q4 and full year 2024 earnings on Wednesday, March 26, 2025, before U.S. markets open.

How can investors join CollPlant's Q4 2024 earnings call?

Investors can join via phone (U.S.: 1-877-407-9716, International: 1-201-493-6779) or listen to the live audio webcast on March 26, 2025, at 10:00 a.m. EST.

What is the conference ID for CollPlant's Q4 2024 earnings call?

The conference ID for the earnings call is 13750725.

How can investors submit questions for CollPlant's Q4 2024 earnings call?

Investors can email questions to Dan Ferry at daniel@lifesciadvisors.com up to 24 hours before the call.
Collplant Biotechnologies Ltd

NASDAQ:CLGN

CLGN Rankings

CLGN Latest News

CLGN Stock Data

29.44M
7.65M
10.16%
12.23%
0.04%
Biotechnology
Healthcare
Link
Israel
Rehovot